Source: Annual Congress 2009 - Pulmonary vascular diseases
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Can, I. Tanboga, H. Tokgöz, N. Keles, F. Koca, A. Özkan, E. Türkyilmaz, O. Özveren, K. Sönmez, C. Kaymaz (Istanbul, MUS, Kütahya, Turkey). The effect of long-term specific therapy on clinical outcome, echocardiographic and sympatho-vagal balance as assessed by heart rate variability in pulmonary arterial hypertension. Eur Respir J 2009; 34: Suppl. 53, 3846

Member's Comments

No comment yet.

Related content which might interest you: Effects of a physical training protocol on heart rate kinetics and heart rate variability indexes in patients with pulmonary arterial hypertension. Source: International Congress 2019 – Exercise and rehabilitation in patients with acute and chronic respiratory diseases Year: 2019 Prognostic implications of delayed heart rate recovery from maximal-incremental exercise in patients with pulmonary arterial hypertension Source: Annual Congress 2012 - Limiting factors in exercise Year: 2012 Impaired cardiac autonomic control relates to disease severity in pulmonary hypertension Source: Eur Respir J 2009; 34: 895-901 Year: 2009 The use of non-invasive stroke volume measurement to assess treatment response in pulmonary arterial hypertension Source: Annual Congress 2010 - Pulmonary vascular diseases Year: 2010 Correlation between sympathovagal modulation and functional capacity in pulmonary arterial hypertension patients. Source: International Congress 2018 – Pulmonary hypertension: right ventricle function, haemodynamics and exercise Year: 2018 A lower resting heart rate may be prognostically favourable in pulmonary arterial hypertension Source: Annual Congress 2011 - Physiology of human pulmonary hypertension Year: 2011 Clinical, functional and hemodynamic response after six months of sildenafil in patients with pulmonary arterial hypertension Source: Annual Congress 2007 - Pulmonary circulation Year: 2007 Haemodynamics, exercise capacity and clinical events in pulmonary arterial hypertension Source: Eur Respir J 2013; 42: 414-424 Year: 2013 Renal dysfunction correlates with impaired hemodynamics and unfavorable outcome in pulmonary arterial hypertension Source: Annual Congress 2010 - Pulmonary circulation: clinical aspects Year: 2010 The rehabilitative treatment by Free-aspireÒ can reduce pulmonary hypertension in patients with post- cardiac surgery heart failure. Hemodynamic evaluation of echocardiographic parameters Source: Annual Congress 2010 - Pulmonary vascular diseases Year: 2010 Pulmonary pressure at rest and during slight exercise might have prognostic relevance in patients at risk for pulmonary arterial hypertension Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases Year: 2008 The effects of beta-blocker therapy on heart rate, symptoms and exercise in pulmonary arterial hypertension Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment Year: 2013 A simple echocardiographic estimate of right ventricular-arterial coupling to assess severity and outcome in pulmonary hypertension on chronic lung disease Source: Eur Respir J, 54 (3) 1802435; 10.1183/13993003.02435-2018 Year: 2019 Hemodynamics as a substitute for exercise capacity endpoints in patients with pulmonary arterial hypertension (PAH): A model based assessment for sildenafil Source: Annual Congress 2010 - Present and future medical management of pulmonary arterial hypertension Year: 2010 Exercise ventilatory inefficiency is an independent predictor of mortality in patients with pulmonary arterial hypertension Source: Annual Congress 2012 - Limiting factors in exercise Year: 2012 Stroke volume and heart rate response to exercise differ in pulmonary arterial hypertension and left heart failure Source: Annual Congress 2009 - Pulmonary arterial hypertension Year: 2009 Tadalafil improves exercise capacity and delays time to clinical worsening in patients with pulmonary arterial hypertension (PAH) Source: Annual Congress 2008 - Medical treatment of pulmonary hypertension Year: 2008 Early improvements predict outcomes in pulmonary arterial hypertension Source: International Congress 2018 – Risk stratification in treatment of pulmonary arterial hypertension Year: 2018 Exercise oxygen uptake efficiency slope independently predicts poor outcome in pulmonary arterial hypertension Source: Eur Respir J 2014; 43: 1510-1512 Year: 2014 Prognostic factors in pulmonary arterial hypertension: assessing the course of the disease Source: Eur Respir Rev 2011; 20: 236-242 Year: 2011